The present study suggests that LOX-1 and its splice variant Δ4 could exert an oncogenic role on breast cancer tissues, and the expression pattern could be specifically modulated in different breast cancer phenotypes, concurring to affect the proliferation rate, the apoptosis induction, the DNA repair processes, and the epigenetic state of cancer cells. The gene discussed is OLR1; the disease is breast carcinoma.